Posted on April 24th, 2012, 3:51 pm
MedPage Today By Chris Kaiser, Cardiology Editor, MedPage Today WASHINGTON -- A novel subcutaneous implantable cardioverter-defibrillator has met its primary safety and effectiveness endpoints, but questions remain regarding the totality of safety and efficacy, ... |